Multiple sclerosis (MS) is a debilitating disease of the brain and spinal cord that impacts millions worldwide.

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

There’s a new Muse in town. Sanofi, Formation Bio and OpenAI have ... with an initial rollout expected for phase 3 tests of ...

Three UK patients have received “groundbreaking” treatment for the disease lupus, which could end their need for lifelong ...

The new indictment adds three killings — including two in Nassau County — to others charges lodged against the gang members, ...

The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

The death of a nurse from North Lanarkshire has been linked to the use of a weight-loss drug recently approved for use on the ...

Out-of-pocket costs for branded drugs to treat multiple sclerosis (MS), Alzheimer's, and Parkinson's disease rose from 2012 ...

In high school Hayley Piggot tried every chemical, cream, and bleach to fight the painful pus-filled acne pimples on her face ...